Bioscience Co. Settles Challenge To $70M Private Placement

Selecta Biosciences Inc. has agreed to limit terms of stock warrants worth millions in cash to directors who participated in a larger, and allegedly unfair, $70 million private placement, as part...

Already a subscriber? Click here to view full article